|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||
| (Accretion) Amortization of investment discounts/premiums, net | |||||
| Accretion of deferred financing costs, debt issuance costs, and Securitized debt discounts/premiums, net | |||||
| Net unrealized (gains) losses on derivatives | |||||
| Proceeds (payments) for derivative settlements | |||||
| Margin (paid) received on derivatives | |||||
| Net unrealized (gains) losses on financial instruments at fair value | |||||
| Net realized losses (gains) on sales of investments | |||||
| Other investment (gains) losses | |||||
| Net increase in provision for credit losses | |||||
| Variable Interest Entities, Primary Beneficiary | |||||
| Total net increase in provision for credit losses | |||||
| Amortization of intangibles and depreciation expenses | |||||
| Gain on origination and sale of loans, net | |||||
| (Gain) loss on extinguishment of debt | |||||
| Equity-based compensation expense | |||||
| Non-cash imputed compensation related to business acquisition | |||||
| Direct loan origination costs, net | |||||
| Sales, settlements and proceeds from sale of loans held-for-sale | |||||
| Fair Value adjustment on mortgage loans held-for-sale | |||||
| Changes in operating assets: | |||||
| (Increase) decrease in accrued interest receivable, net | |||||
| Decrease (increase) in other assets | |||||
| Changes in operating liabilities: | |||||
| (Decrease) increase in accounts payable and other liabilities | |||||
| Increase in accrued interest payable, net | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash Flows From Investing Activities: | |||||
| Purchases | |||||
| Agency MBS portfolio | |||||
| Non-Agency RMBS | |||||
| Sales | |||||
| Agency MBS portfolio | |||||
| Non-Agency RMBS | |||||
| Loans Held for Investment | |||||
| Principal payments | |||||
| Agency MBS portfolio | |||||
| Non-Agency RMBS | |||||
| Loans Held for Investment | |||||
| Purchases | |||||
| Payments on purchases of investment in MSR financing receivables | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash Flows From Financing Activities: | |||||
| Proceeds from secured financing agreements | |||||
| Payments on secured financing agreements | |||||
| Payments on repurchase of common stock | |||||
| Proceeds on issuance of common stock | |||||
| Proceeds from securitized debt borrowings, collateralized by Loans held for investment | |||||
| Payments on securitized debt borrowings, collateralized by Loans held for investment | |||||
| Payments on securitized debt borrowings, collateralized by Non-Agency RMBS | |||||
| Payments on convertible debt purchases | |||||
| Settlement of warrants | |||||
| Net proceeds from issuance of unsecured debt | |||||
| Common dividends paid | |||||
| Preferred dividends paid | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest received | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Change in fair value of contingent earn-out liability | |||||
| Non-cash investing activities: | |||||
| Payable for investments purchased | |||||
| Net change in unrealized gain (loss) on available-for sale securities | |||||
| Retained beneficial interests | |||||
| Non-Agency RMBS, at fair value | |||||
| Non-Cash Consideration paid for HomeXpress | |||||
| Non-cash financing activities: | |||||
| Conversion of convertible debt | |||||
| Dividends declared, not yet paid | |||||
Loading...